In this study, we aimed to explore the relationship of CCND1 copy number alteration and cyclin D1 protein expression in acral melanoma, and to determine whether anti-cyclin D1 IHC may be used as a surrogate for direct evaluation of increase in CCND1 copy number. The gene discussed is CCND1; the disease is melanoma.